Back to mobile site

Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c

November 1, 2011 4:48 PM EDT
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings